Compare stocks

Bonesupport Holding AB, founded in 1999 and headquartered in Lund, Sweden, specializes in developing and commercializing injectable bio-ceramic bone graft substitutes under the CERAMENT® brand. These products are designed to remodel into the patient's own bone and can elute drugs directly into bone voids. The company's portfolio includes CERAMENT® Bone Void Filler, CERAMENT® G, and CERAMENT® V, targeting conditions such as bone voids resulting from trauma, infection, or disease. In 2024, Bonesupport reported net sales of SEK 898.7 million, marking a 52% increase from the previous year. The company operates in Europe, North America, and other international markets, focusing on orthobiologics for bone injury management.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.